The stem cell transcription factor ZFP57 induces IGF2 expression to promote anchorage-independent growth in cancer cells

[1]  G. Grimaldi,et al.  Genetic and epigenetic mutations affect the DNA binding capability of human ZFP57 in transient neonatal diabetes type 1 , 2013, FEBS letters.

[2]  J. Baron,et al.  Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3 , 2013, Proceedings of the National Academy of Sciences.

[3]  篠原 隆司,et al.  Induction of pluripotent stem cell cells from germ cells , 2012 .

[4]  W. Lamers,et al.  Possible roles of DLK1 in the Notch pathway during development and disease. , 2012, Biochimica et biophysica acta.

[5]  Paul Polakis,et al.  Wnt signaling in cancer. , 2012, Cold Spring Harbor perspectives in biology.

[6]  E. Giannoni,et al.  Anoikis: an emerging hallmark in health and diseases , 2012, The Journal of pathology.

[7]  M. Kyba,et al.  Zinc Finger Protein ZFP57 Requires Its Co-factor to Recruit DNA Methyltransferases and Maintains DNA Methylation Imprint in Embryonic Stem Cells via Its Transcriptional Repression Domain* , 2011, The Journal of Biological Chemistry.

[8]  D. Trono,et al.  In Embryonic Stem Cells, ZFP57/KAP1 Recognize a Methylated Hexanucleotide to Affect Chromatin and DNA Methylation of Imprinting Control Regions , 2011, Molecular cell.

[9]  Thomas Tuschl,et al.  miRNAs in human cancer , 2011, The Journal of pathology.

[10]  J. Rinn,et al.  Large non-coding RNAs: missing links in cancer? , 2010, Human molecular genetics.

[11]  Jeffrey T. Chang,et al.  Anchorage-independent cell growth signature identifies tumors with metastatic potential , 2009, Oncogene.

[12]  G. Daley,et al.  Functional Evidence that the Self‐Renewal Gene NANOG Regulates Human Tumor Development , 2009, Stem cells.

[13]  M. Pollak,et al.  Insulin and insulin-like growth factor signalling in neoplasia , 2008, Nature Reviews Cancer.

[14]  P. Leder,et al.  A maternal-zygotic effect gene, Zfp57, maintains both maternal and paternal imprints. , 2008, Developmental cell.

[15]  A. Hattersley,et al.  Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57 , 2008, Nature Genetics.

[16]  A. Regev,et al.  An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.

[17]  P. D'Amore,et al.  IGF2: epigenetic regulation and role in development and disease. , 2008, Cytokine & growth factor reviews.

[18]  J. Cavaille,et al.  Non‐coding RNAs in imprinted gene clusters , 2008, Biology of the cell.

[19]  J. Nichols,et al.  Nanog safeguards pluripotency and mediates germline development , 2007, Nature.

[20]  Alexei A. Sharov,et al.  Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells , 2007, Nature Cell Biology.

[21]  T. Yokota,et al.  β-Catenin up-regulates Nanog expression through interaction with Oct-3/4 in embryonic stem cells , 2007 .

[22]  Hitoshi Niwa,et al.  How is pluripotency determined and maintained? , 2007, Development.

[23]  D. Leroith,et al.  The role of the IGF system in cancer growth and metastasis: overview and recent insights. , 2007, Endocrine reviews.

[24]  P. Jelinic,et al.  Loss of imprinting and cancer , 2007, The Journal of pathology.

[25]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[26]  H. Niwa,et al.  Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. , 2006, Biochemical and biophysical research communications.

[27]  X. Chen,et al.  The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells , 2006, Nature Genetics.

[28]  R. Jaenisch,et al.  Global loss of imprinting leads to widespread tumorigenesis in adult mice. , 2005, Cancer cell.

[29]  Megan F. Cole,et al.  Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells , 2005, Cell.

[30]  M. Ko,et al.  Identification of Zfp-57 as a downstream molecule of STAT3 and Oct-3/4 in embryonic stem cells. , 2005, Biochemical and biophysical research communications.

[31]  J. Auwerx,et al.  Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Mirsky,et al.  Identification and Characterization of ZFP-57, a Novel Zinc Finger Transcription Factor in the Mammalian Peripheral Nervous System* , 2004, Journal of Biological Chemistry.

[33]  Hua Yu,et al.  The STATs of cancer — new molecular targets come of age , 2004, Nature Reviews Cancer.

[34]  M. Murakami,et al.  The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells , 2003, Cell.

[35]  J. Nichols,et al.  Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells , 2003, Cell.

[36]  J. Miyazaki,et al.  Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells , 2000, Nature Genetics.

[37]  M. Katsuki,et al.  STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells , 1999, The EMBO journal.

[38]  H. Schöler,et al.  Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4 , 1998, Cell.

[39]  A. Smith,et al.  Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. , 1998, Genes & development.

[40]  G. Martin,et al.  Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[42]  I. Fidler,et al.  Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[43]  上田 篤.  Involvement of Gli proteins in undifferentiated state maintenance and proliferation of embryonic stem cells , 2012 .

[44]  L. Larsen,et al.  The hedgehog signaling pathway in cancer. , 2005, Progress in molecular and subcellular biology.

[45]  Zang Ai-hua,et al.  Stem Cells,Cancer and Cancer Stem Cells , 2005 .

[46]  P. Greengard,et al.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor , 2004, Nature Medicine.

[47]  小出 麗,et al.  Involvement of Ras in extraembryonic endoderm differentiation of embryonic stem cells , 2004 .

[48]  A. Smith,et al.  Embryo-derived stem cells: of mice and men. , 2001, Annual review of cell and developmental biology.

[49]  岡崎 伸治.  A novel nuclear protein with zinc fingers down-regulated during early mammalian cell differentiation , 1994 .